Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 65

Sort by

Sort Order Select

Journal Articles

Abstract 1524: The cancer specific intramembrane serine protease RHBDL2 serves as a master regulator of glutamine metabolism and chemoresistance in TNBC

Yosuke Matsushita, Kazumasa Okumura, Masato Komatsu, Tetsuro Yoshimaru, Masaya Ono, Mitsunori Sasa, Yasuo Miyoshi, Toyomasa Katagiri

Cancer Res (2025) 85 (8_Supplement_1): 1524.

https://doi.org/10.1158/1538-7445.AM2025-1524

Published: 21 April 2025

View articletitled, Abstract 1524: The cancer specific intramembrane serine protease RHBDL2 serves as a master regulator of glutamine metabolism and chemoresistance in TNBC

Journal Articles

Abstract 7055: Elucidation of the interplay between phospholipid byosynthesis and oxidative stress in the pathogenesis of renal cell carcinoma

Renpei Kato, Daiki Ikarashi, Shigekatsu Maekawa, Mitsugu Kanehira, Ryo Takata, Yosuke Matsushita, Tetsuro Yoshimaru, Tomoya Fukawa, Toyomasa Katagiri, Wataru Obrara

Cancer Res (2024) 84 (6_Supplement): 7055.

https://doi.org/10.1158/1538-7445.AM2024-7055

Published: 22 March 2024

View articletitled, Abstract 7055: Elucidation of the interplay between phospholipid byosynthesis and oxidative stress in the pathogenesis of renal cell carcinoma

Journal Articles

Abstract 3813: PHB2 inactivation by AKAP-BIG3 is required for progression of HER2-overexpressing breast cancer

Tetsuro Yoshimaru, Yosuke Matsushita, Mitsunori Sasa, Yasuo Miyoshi, Toyomasa Katagiri

Cancer Res (2019) 79 (13_Supplement): 3813.

https://doi.org/10.1158/1538-7445.AM2019-3813

Published: 01 July 2019

View articletitled, Abstract 3813: PHB2 inactivation by AKAP-BIG3 is required for progression of HER2-overexpressing breast cancer

Journal Articles

Abstract 5313: Frequent downregulation of SALL3 by genetic and epigenetic alterations is involved in progression and chemoresistance of triple negative breast cancers

Yosuke Matsushita, Masato Komatsu, Kazuma Kiyotani, Tetsuro Yoshimaru, Hiromu Suzuki, Yasuo Miyoshi, Mitsunori Sasa, Toyomasa Katagiri

Cancer Res (2019) 79 (13_Supplement): 5313.

https://doi.org/10.1158/1538-7445.AM2019-5313

Published: 01 July 2019

View articletitled, Abstract 5313: Frequent downregulation of SALL3 by genetic and epigenetic alterations is involved in progression and chemoresistance of triple negative breast cancers

Journal Articles

Abstract 5315: Frequent downregulation of SALL3 by recurrent genetic and epigenetic alterations is involved in triple-negative breast cancers

Yosuke Matsushita, Masato Komatsu, Kazuma Kiyotani, Tetsuro Yoshimaru, Hiromu Suzuki, Yasuo Miyoshi, Mitsunori Sasa, Toyomasa Katagiri

Cancer Res (2018) 78 (13_Supplement): 5315.

https://doi.org/10.1158/1538-7445.AM2018-5315

Published: 01 July 2018

View articletitled, Abstract 5315: Frequent downregulation of SALL3 by recurrent genetic and epigenetic alterations is involved in triple-negative breast cancers

Journal Articles

Abstract 1837: Overcoming trastuzumab resistance in HER2-overexpressing breast cancer by utilizing PHB2, a tumor suppressor of multiple resistance pathways

Tetsuro Yoshimaru, Yosuke Matsushita, Mitsunori Sasa, Yasuo Miyoshi, Toyomasa Katagiri

Cancer Res (2018) 78 (13_Supplement): 1837.

https://doi.org/10.1158/1538-7445.AM2018-1837

Published: 01 July 2018

View articletitled, Abstract 1837: Overcoming trastuzumab resistance in HER2-overexpressing breast cancer by utilizing PHB2, a tumor suppressor of multiple resistance pathways

Journal Articles

Abstract 94: DDX31 cooperates with mutant p53 and EGFR to promote the multistep progression of invasive bladder cancer

Toyomasa Katagiri, Kei Daizumoto, Tetsuro Yoshimaru, Yosuke Matsushita, Tomoya Fukawa, Masaya Ono, Hiro-omi Kanayama

Cancer Res (2018) 78 (13_Supplement): 94.

https://doi.org/10.1158/1538-7445.AM2018-94

Published: 01 July 2018

View articletitled, Abstract 94: DDX31 cooperates with mutant p53 and EGFR to promote the multistep progression of invasive bladder cancer

Journal Articles

A DDX31/Mutant–p53/EGFR Axis Promotes Multistep Progression of Muscle-Invasive Bladder Cancer

Kei Daizumoto, Tetsuro Yoshimaru, Yosuke Matsushita, Tomoya Fukawa, Hisanori Uehara, Masaya Ono, Masato Komatsu, Hiro-omi Kanayama, Toyomasa Katagiri

Cancer Res (2018) 78 (9): 2233–2247.

https://doi.org/10.1158/0008-5472.CAN-17-2528

Published: 30 April 2018

View articletitled, A DDX31/Mutant–p53/EGFR Axis Promotes Multistep Progression of Muscle-Invasive Bladder Cancer

Includes: Supplementary data

Journal Articles

Abstract 3613: Development of chemically modified peptide inhibitor ERAP targeting BIG3-PHB2 complex on hormone-resistant breast tumor

Toyomasa Katagiri, Tetsuro Yoshimaru

Cancer Res (2017) 77 (13_Supplement): 3613.

https://doi.org/10.1158/1538-7445.AM2017-3613

Published: 01 July 2017

View articletitled, Abstract 3613: Development of chemically modified peptide inhibitor ERAP targeting BIG3-PHB2 complex on hormone-resistant breast tumor

Journal Articles

Abstract 1710: Xanthohumol suppresses estrogen-signaling in endocrine resistant breast cancer through the specific inhibition of BIG3-PHB2 interactions

Toyomasa Katagiri

Cancer Res (2015) 75 (15_Supplement): 1710.

https://doi.org/10.1158/1538-7445.AM2015-1710

Published: 01 August 2015

View articletitled, Abstract 1710: Xanthohumol suppresses estrogen-signaling in endocrine resistant breast cancer through the specific inhibition of BIG3-PHB2 interactions

Journal Articles

Abstract 623: BIG3-PHB2 interaction is a key therapeutic target in luminal-type of breast cancer

Toyomasa Katagiri, Tesuro Yoshimaru, Masato Komatsu, Taisuke Matsuo

Cancer Res (2014) 74 (19_Supplement): 623.

https://doi.org/10.1158/1538-7445.AM2014-623

Published: 01 October 2014

View articletitled, Abstract 623: BIG3-PHB2 interaction is a key therapeutic target in luminal-type of breast cancer

Journal Articles

Abstract 320: Frequent inactivation of the Mieap-regulated mitochondrial quality control in pancreatic and breast cancer

Hiroki Kamino, Yasuyuki Nakamura, Hitoya Sano, Ryuya Murai, Yuri Saito, Manabu Futamura, Kazuhiro Yoshida, Nobuyoshi Hiraoka, Yae Kanai, Ryoji Kushima, Toyomasa Katagiri, Hirofumi Arakawa

Cancer Res (2014) 74 (19_Supplement): 320.

https://doi.org/10.1158/1538-7445.AM2014-320

Published: 01 October 2014

View articletitled, Abstract 320: Frequent inactivation of the Mieap-regulated mitochondrial quality control in pancreatic and breast cancer

Journal Articles

Abstract 3226: GALNT6 stabilizes GRP78 protein by O-type glycosylation

Jae-Hyun Park, Suyoun Chung, Jiaying Lin, Koji Ueda, Toyomasa Katagiri, Yusuke Nakamura

Cancer Res (2014) 74 (19_Supplement): 3226.

https://doi.org/10.1158/1538-7445.AM2014-3226

Published: 01 October 2014

View articletitled, Abstract 3226: GALNT6 stabilizes GRP78 protein by O-type glycosylation

Journal Articles

Abstract 765: DDX31 regulates p53 tumor suppressive activity in renal cell carcinomas.

Toyomasa Katagiri, Tomoya Fukawa, Taisuke Matsuo, Hiro-omi Kanayama

Cancer Res (2013) 73 (8_Supplement): 765.

https://doi.org/10.1158/1538-7445.AM2013-765

Published: 15 April 2013

View articletitled, Abstract 765: DDX31 regulates p53 tumor suppressive activity in renal cell carcinomas.

Journal Articles

DDX31 Regulates the p53-HDM2 Pathway and rRNA Gene Transcription through Its Interaction with NPM1 in Renal Cell Carcinomas

Tomoya Fukawa, Masaya Ono, Taisuke Matsuo, Hisanori Uehara, Tsuneharu Miki, Yusuke Nakamura, Hiro-omi Kanayama, Toyomasa Katagiri

Cancer Res (2012) 72 (22): 5867–5877.

https://doi.org/10.1158/0008-5472.CAN-12-1645

Published: 14 November 2012

View articletitled, DDX31 Regulates the p53-HDM2 Pathway and rRNA Gene Transcription through Its Interaction with NPM1 in Renal Cell Carcinomas

Includes: Supplementary data

Journal Articles

Cell-Permeable Peptide DEPDC1-ZNF224 Interferes with Transcriptional Repression and Oncogenicity in Bladder Cancer Cells

Yosuke Harada, Mitsugu Kanehira, Yoshiko Fujisawa, Ryo Takata, Taro Shuin, Tsuneharu Miki, Tomoaki Fujioka, Yusuke Nakamura, Toyomasa Katagiri

Cancer Res (2010) 70 (14): 5829–5839.

https://doi.org/10.1158/0008-5472.CAN-10-0255

Published: 14 July 2010

View articletitled, Cell-Permeable Peptide DEPDC1-ZNF224 Interferes with Transcriptional Repression and Oncogenicity in Bladder Cancer Cells

Includes: Supplementary data

Journal Articles

Critical Roles of Mucin 1 Glycosylation by Transactivated Polypeptide N-Acetylgalactosaminyltransferase 6 in Mammary Carcinogenesis

Jae-Hyun Park, Toshihiko Nishidate, Kyoko Kijima, Takao Ohashi, Kaoru Takegawa, Tomoko Fujikane, Koichi Hirata, Yusuke Nakamura, Toyomasa Katagiri

Cancer Res (2010) 70 (7): 2759–2769.

https://doi.org/10.1158/0008-5472.CAN-09-3911

Published: 31 March 2010

View articletitled, Critical Roles of Mucin 1 Glycosylation by Transactivated Polypeptide N-Acetylgalactosaminyltransferase 6 in Mammary Carcinogenesis

Includes: Supplementary data

Journal Articles

Ubiquitination and Downregulation of BRCA1 by Ubiquitin-Conjugating Enzyme E2T Overexpression in Human Breast Cancer Cells

Tomomi Ueki, Jae-Hyun Park, Toshihiko Nishidate, Kyoko Kijima, Koichi Hirata, Yusuke Nakamura, Toyomasa Katagiri

Cancer Res (2009) 69 (22): 8752–8760.

https://doi.org/10.1158/0008-5472.CAN-09-1809

Published: 11 November 2009

View articletitled, Ubiquitination and Downregulation of BRCA1 by Ubiquitin-Conjugating Enzyme E2T Overexpression in Human Breast Cancer Cells

Includes: Supplementary data

Journal Articles

Radioimmunotherapy for human synovial sarcoma xenografts with Yttrium 90-labeled anti-FZD10 monoclonal antibody.

Chikako Fukukawa, Toyomasa Katagiri, Hirofumi Hanaoka, Satoshi Nagayama, Junya Toguchida, Keigo Endo, Yusuke Nakamura

Cancer Res (2008) 68 (9_Supplement): 5754.

Published: 01 May 2008

View articletitled, Radioimmunotherapy for human synovial sarcoma xenografts with Yttrium 90-labeled anti-FZD10 monoclonal antibody.

Journal Articles

A novel glycoproteomic approach for the discovery of carbohydrate-targeting serum tumor markers for lung cancer using Lectin-coupled ProteinChip system

Koji Ueda, Yataro Daigo, Yu Fukase, Toyomasa Katagiri, Nobuhisa Ishikawa, Shinji Irie, Taka-Aki Sato, Nobuoki Kohno, Mieko Shiwa, Yusuke Nakamura

Cancer Res (2008) 68 (9_Supplement): 2433.

Published: 01 May 2008

View articletitled, A novel glycoproteomic approach for the discovery of carbohydrate-targeting serum tumor markers for lung cancer using Lectin-coupled ProteinChip system

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract 1524: The cancer specific intramembrane serine protease RHBDL2 serves as a master regulator of glutamine metabolism and chemoresistance in TNBC

Abstract 7055: Elucidation of the interplay between phospholipid byosynthesis and oxidative stress in the pathogenesis of renal cell carcinoma

Abstract 3813: PHB2 inactivation by AKAP-BIG3 is required for progression of HER2-overexpressing breast cancer

Abstract 5313: Frequent downregulation of SALL3 by genetic and epigenetic alterations is involved in progression and chemoresistance of triple negative breast cancers

Abstract 5315: Frequent downregulation of SALL3 by recurrent genetic and epigenetic alterations is involved in triple-negative breast cancers

Abstract 1837: Overcoming trastuzumab resistance in HER2-overexpressing breast cancer by utilizing PHB2, a tumor suppressor of multiple resistance pathways

Abstract 94: DDX31 cooperates with mutant p53 and EGFR to promote the multistep progression of invasive bladder cancer

A DDX31/Mutant–p53/EGFR Axis Promotes Multistep Progression of Muscle-Invasive Bladder Cancer

Abstract 3613: Development of chemically modified peptide inhibitor ERAP targeting BIG3-PHB2 complex on hormone-resistant breast tumor

Abstract 1710: Xanthohumol suppresses estrogen-signaling in endocrine resistant breast cancer through the specific inhibition of BIG3-PHB2 interactions

Abstract 623: BIG3-PHB2 interaction is a key therapeutic target in luminal-type of breast cancer

Abstract 320: Frequent inactivation of the Mieap-regulated mitochondrial quality control in pancreatic and breast cancer

Abstract 3226: GALNT6 stabilizes GRP78 protein by O-type glycosylation

Abstract 765: DDX31 regulates p53 tumor suppressive activity in renal cell carcinomas.

DDX31 Regulates the p53-HDM2 Pathway and rRNA Gene Transcription through Its Interaction with NPM1 in Renal Cell Carcinomas

Cell-Permeable Peptide DEPDC1-ZNF224 Interferes with Transcriptional Repression and Oncogenicity in Bladder Cancer Cells

Critical Roles of Mucin 1 Glycosylation by Transactivated Polypeptide N-Acetylgalactosaminyltransferase 6 in Mammary Carcinogenesis

Ubiquitination and Downregulation of BRCA1 by Ubiquitin-Conjugating Enzyme E2T Overexpression in Human Breast Cancer Cells

Radioimmunotherapy for human synovial sarcoma xenografts with Yttrium 90-labeled anti-FZD10 monoclonal antibody.

A novel glycoproteomic approach for the discovery of carbohydrate-targeting serum tumor markers for lung cancer using Lectin-coupled ProteinChip system

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only